4+ day, 19+ min ago   (565+ words) An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines' hedgehog pathway inhibitor taladegib, in development for idiopathic pulmonary fibrosis (IPF). The post hoc analysis of the study showed that…...

4+ day, 1+ hour ago   (441+ words) Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial intelligence is having that moment now. Unlike some previous waves of hype, this one is grounded in something real, but only if…...

4+ day, 23+ hour ago   (809+ words) Drug development is an inherently risky endeavour, with the average probability of approval for a drug entering Phase I studies now sitting at just 6.7%. While much of this can be attributed to lack of efficacy, factors such as poor clinical…...

5+ day, 22+ hour ago   (1068+ words) The life sciences sector has never been more innovative. Every year, hundreds of new companies are founded around promising therapies, diagnostics, medical technologies, and AI-enabled healthcare platforms. Many begin life with a handful of employees, modest operating budgets, and an…...

1+ week, 1+ day ago   (824+ words) This June marked the third such Women in AI event, taking place at a time when AI in medicine has progressed from pilot to infrastructure. Guest female speakers included: Dr Anushka Patchava, chief clinical & innovation officer, Cignpost; Nora Lamoudi-Sutcliffe, senior…...

1+ week, 1+ day ago   (782+ words) EVERSANA CEO Mark Thierer speaks at the EVERSANA-Google event in New York City last week. Editor's Note: pharmaphorum is an editorially independent publication owned by EVERSANA. It’s been one year since EVERSANA rolled out its ambitious AI agency in partnership…...

1+ week, 3+ day ago   (499+ words) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has followed through on plans to roll out regional 'sandboxes' for NHS innovations, to operate alongside its centralised initiatives, via a partnership with Manchester University NHS Foundation Trust (MFT). MHRA's first…...

1+ week, 6+ day ago   (730+ words) Artificial intelligence (AI) is quietly reshaping pharmaceutical research. Driven by promises of faster trial design and drug discovery, the global AI-in-pharma market is projected to grow over 40% annually through 2030. Yet, for US drug developers, bringing these tools across the Atlantic…...

2+ week, 3+ day ago   (1596+ words) In the third and final part of this longevity series, I discuss how science discovers what extends life. Healthcare treats its failure, too late. In between these two sits the layer where outcomes are actually determined: daily behaviour. This is…...

2+ week, 4+ day ago   (686+ words) AI has kickstarted a new wave of innovation in biopharma R&D, reshaping how organisations approach some of the most complex and high-stakes decision making in science and medicine. As advances in computing power, data availability, and generative AI converge,…...